In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Using Actigraphy Generated Sleep in Alzheimer's Disease
Read more on 'The Case for using actigraphy generated sleep and activity endpoints in Alzheimer's disease'.
-
Patient-Centric Trial Recruitment
Commentary from EB McLindon on the challenges ofpatient recruitment and the need for current recruitment methods to evolve, especially for trials involving rare diseases and oncology.
-
CRO Trends 2018
CRO trends in 2018, including improving productivity, cycle times and reducing costs. In addition, key development challenges are addressed through big data partnerships, patient recruitment and applied innovation.
-
Bring Your Own Device ePRO
Bill Byrom and Willie Muehlhausen share their insights into the drive to design morepatient-centric trials, and how leveraging patients' own devices could enable the collection of patient-reported outcomes (PRO) data.
-
mHealth: Changing the Dynamics of the Healthcare Ecosystem
Vicki Anastasi discuss how mHealth is changing medical device clinical trials in this Pharmaceutical Executive article
-
Tackling RWE Challenges To Demonstrate Healthcare Value
A thought-leadership piece co-authored by Michael Pace and Jim Carroll, on the expected impact and challenges ofreal world evidence (RWE)on how healthcare technologies will be developed and consumed.
-
-
Must-Know FDA Guidance Documents from 2017
A thought-leadership piece co-authored by Cynthia Nolte, Sandra D. Maher, and Ashleigh Dawley on the new and updated guidance documents issued by the FDA in 2017, focusing on those important formedical manufacturersand the industry.
-
Putting Patients to the Forefront
Featuring commentary from Tom O’Leary in an Irish Times article on the potential of digital technology to create a new patient-centric business model.
-
Access and Reimbursement for Adoptive T-Cell Transfer Drugs
ICON experts inoncology and pricing & market accessshare their thoughts on offsetting payer obstacles in this Pharmaceutical Executive article.
